Home Blog Page 4

Why An Oil Company Plans To Build California’s Biggest Solar Energy Project

0

Another step in the ongoing decarbonization of fossil fuels.

The Belridge oil field in the San Joaquin Valley of California has produced about 1.7 billion barrels of heavy crude since its discovery in 1911. Thanks to advances in solar power, its next 500 million barrels will be a little bit greener.

Here in the middle of the 22-mile long oilfield Aera Energy is set to spend an estimated $250 million to build California’s largest solar energy project. The centerpiece will be 630 acres of glass houses, like greenhouses on farms. Hung inside the glass boxes will be solar collectors — basically flimsy mirrors made from sheets of aluminum foil and suspended by wires. As the sun moves across the sky, small motors pull the wires to adjust the mirrors’ pitch. The reflected rays are concentrated on a network of pipes carrying water throughout the glass block, creating steam. The plan at Belridge is to use the sun’s power to make 12 million barrels of steam per year.

What’s the steam for? Well Belridge is what you’d call a geriatric oil field. Its oil no longer flows under its own natural pressure, so its operator, Aera Energy, is continuously injecting steam into the reservoir rock in order to loosen up and coax out more oil. The so-called steam floods have been going on so long at old fields throughout the region around Bakersfield, Calif., that oftentimes more than 95% of the fluid that comes out of the ground is water. After the oil is skimmed off, the water is repressurized and injected right back down into the reservoir.Production at Belridge peaked at 160,000 barrels per day in 1986, and today it is still doing 76,000 bpd — a rate that Christina Sistrunk, CEO of Aera Energy, thinks it can keep up for the next 20 years. That long life expectancy is why is makes economic sense for Aera to invest an estimated $250 million with GlassPoint to build its solar technology.

With solar, you make your big investments upfront, then effectively get your fuel for free when the sun shines. Otherwise, when burning natural gas, Aera faces continual fuel bills, and gets dinged by California regulators for its industrial carbon emissions. The Glasspoint installation will eliminate 375,000 tons of carbon emissions each year, and offset about 4.9 billion cubic feet of natural gas use. At about $3 per thousand cubic feet, that works out to about $15 million in gas savings per year for fuel. Carbon credits are trickier to figure. Recent auction prices under the California-Canada carbon cap-and-trade program have come in at around $14.50 per ton. Outyear estimates are higher. Belridge carbon reductions might then be worth roughly $5 million per year? Aera’s Sistrunk won’t comment on such speculations. What she will say is that even with cap-and-trade and the natural gas savings, and other state and federal incentives, this solar project “is not overwhelmingly economically robust.”

So why go to the trouble? Because it looks good to do solar projects. And because California, despite being the epitome of America’s car culture, has made it an ever harder place for oil companies to maintain a “social license” to operate. “It’s a challenge in California, where you need your performance to be even stronger to offset the regulatory costs of doing business here,” says Sistrunk. “Previously we couldn’t afford to do it.”

Six years ago Glasspoint built its first glass houses for Berry Petroleum at another Kern County oilfield. That caught the eye of the Gulf sultanate of Oman, leading to a $600 million contract to build a 1,000 mw system to support steam-flooded oil production there. It’s surprising, but “natural gas in the Middle East is not evenly distributed,” says GlassPoint CEO Ben Bierman. Qatar and Iran have a lot of gas, while Oman, Kuwait and Saudi Arabia are relatively short. As a result, planning for big capital projects in the region assume long-term gas at $5.50 to $7 per mmBTU. That’s double the prevailing price at Henry Hub in Louisiana.

What’s exciting about the Aera Energy deal for GlassPoint is that it gives them an implicit seal of approval from ExxonMobil and Shell, which signed off on their JV’s investment. Bierman claims that scaling up its business to supply the Oman project (operated by Shell) has enabled Glasspoint to reduce its costs by 55%. Bierman says their objective is to make the system as simple and foolproof as possible by tapping into supply chains that serve the much-larger agricultural market. He predicts big growth ahead in markets that are already ramping up big steam floods like Bahrain, Kuwait and especially Saudi Arabia. Further out he has his eye on Indonesia and China. There’s no supply bottleneck in the way of growing to eight times their current size, says Bierman, who now lives in Oman. “The stars finally aligned.” Thanks to the oil business, in a decade GlassPoint could be among the biggest solar companies in the world.

Meredith Corp. Acquires Time Inc. In $2.8 Billion Koch Brothers-Backed Deal

0

U.S. media group Meredith has reached a deal to acquire Time, the U.S. publisher of Sports Illustrated and Fortune magazines, the company said Sunday evening.

Meredith said it had entered a binding agreement to acquire all outstanding shares of Time for $18.50 per share in an all-cash transaction valued at $2.8 billion. The transaction is expected to close during the first quarter of calendar 2018, the company said.

The acquisition is a coup for Meredith, which held unsuccessful talks to buy Time earlier this year as well as in 2013. Analysts have said that bulking up on publishing assets could give Meredith the scale required to spin off its broadcasting arm into a standalone company.

Meredith’s bid for Time is backed by an affiliate of billionaire brothers Charles and David Koch.

Wall Street, New York, NY, United States of AmericaKoch Industries has been backing Meredith’s bid with $600 million in financing, sources previously told Reuters. It is not clear how much influence the Koch brothers would have over the combined publishing company. Koch Industries, which owns brands such as Brawny paper towels, Dixie Cups and Lycra, is controlled by Charles and David Koch, two of the worlds richest men.

The Kochs are known for their conservative views and views on economic freedom. They have previously expressed interest in buying media properties such as the Los Angeles Times and the Chicago Tribune in 2013.

Meredith, which publishes Better Homes & Gardens and Family Circle magazines, has a market capitalization of $2.7 billion. It tried to merge with Richmond, Virginia-based broadcaster Media General in 2015, but Nexstar Media Group ended up acquiring that company for $4.6 billion.

Time, which also publishes the eponymous current affairs magazine, has been struggling in an industry-wide decline in print media, as circulation shrinks and advertisers shift to
digital platforms.

Time ended trading on Friday at $16.90 per share, giving it a market capitalization of $1.68 billion.

Time, led by Chief Executive Rich Battista, has been undergoing a strategic plan that includes revamping its cost structure and focusing on its digital business. It has been exploring a sale of several magazines titles, such as Coastal Living, Sunset and Golf magazine and a majority stake in Essence Magazine as well as Time UK.

The assets it had earmarked for a potential sale represented about $488 million in revenue for the year ended June 30, the company has said.

In September, it named its former digital editor, Edward Felsenthal, to be the new editor in chief of Time Magazine. It has also expanded into streaming video channels, launching Sports Illustrated TV through Amazon earlier this month.

Time said earlier in November that in the third quarter, its total revenue slipped 9.5 percent to $679 million, missing analysts’ estimates of $693.5 million, according to Thomson Reuters. It marked the sixth straight quarter the company had missed expectations for revenue.

Invisible Product Drives Enormous Investor Profits

0

Invisalign is one of the hottest products of the year thanks to teens and adults who want straight teeth without metal in their mouths.
The shift to clear aligners has powered Align Technology (ALGN), the company behind Invisalign, to a record year. Align’s value has nearly tripled, making it the top performer on the S&P 500. It’s worth close to $20 billion.

“Braces are no longer a right of passage for teens,” said Jeff Johnson, an RW Baird analyst. Invisalign is “quickly moving into the mass adoption part of the market.”

More than a million teens across the globe have ordered Invisalign, Align announced in November. Five million people have purchased the treatment, which costs anywhere between $3,000 – $8,000.

Align sales have grown two years in a row, and its last quarter was the best in the company’s 20-year history.

Orders among teens spiked to nearly 70,000 this past quarter, a 46% rise compared to the same period last year. Credit Suisse analyst Erin Wright called the jump “momentous.”

The company’s strategy to expand internationally over the past several years — especially in China — has fueled growth. China became Invisalign’s second-biggest market behind the United States for the first time last quarter.

Align has also aggressively targeted both patients and doctors in a push to disrupt the orthodontic industry.

“They make no qualms that they would like to be a major form of orthodontic treatment,” said Dr. Olivier Nicolay, a professor at NYU’s College of Dentistry.

Align has ramped up advertising spending 60% this year as part of its effort to highlight the product’s aesthetic and lifestyle advantages over braces to teens and their parents.

“You can pull them out to eat the food that you want or play a sport or play a musical instrument,” CEO Joe Hogan told CNNMoney in an interview. “You can live the life that you want to live.”

Product advancements and Align’s efforts to train a network of more than 125,000 orthodontists and dentists around the world have also expanded its reach.

“There’s been an evolution of this technology. We’ve invested a significant amount of money,” said Hogan. “Years ago we weren’t capable of doing a lot of the cases that are out there.”

Once skeptical that clear aligners could deliver the same results as wires and brackets, orthodontists are now more comfortable putting patients on the treatment.

“Orthodontists are no longer scared of it,” said Dr. Nicolay. “Invisalign has become an accepted procedure for adults and for adolescents.”

Dentists are also eager for new revenue drivers to offset a sluggish recovery in patient levels a decade after the recession, noted William Blair analyst John Kreger.

With few major competitors looming, a tight grip on the dozens of patents that go into producing clear aligner technology and strong brand recognition, Align’s looks poised to continue its climb into next year and beyond.

And the untapped teen orthodontic market has analysts increasingly bullish about the company’s long-term prospects.

Teens account for roughly three-quarters of the 10 million orthodontic cases each year, but only 3% of them use Invisalign.

“We see no reason why it couldn’t surpass 10% in the next five years,” predicted Kreger.

Now Is the Perfect Time For Apple To Buy Netflix

0

A huge cash horde, coupled with $200 billion in repatriated cash from recently passed tax reform, is a perfect opportunity for Apple to make a big purchase of a company such as Netflix.

American companies should get a huge shot in the arm from the new tax cut plan, but perhaps none more than Apple, Inc. (Nasdaq: AAPL). In fact, if Apple is ever going to make a big splash with a huge blockbuster buyout, some analysts are speculating it’s now or never.

UBS estimates the rate cut from 35 to 21 percent will boost earnings for Standard & Poor’s 500 index stocks by an average of 9 percent, and Apple is no exception. However, the most important part of tax reform for Apple and its shareholders is the repatriation tax holiday, which will allow companies with cash stored overseas to bring that cash back into the American economy at a reduced rate of 15.5 percent.

Apple (APPL) 1-Year Chart

GBH Insights head of technology research Daniel Ives says Apple will opt to return roughly $200 billion of its overseas cash thanks to the holiday. Ives says he anticipates U.S. companies will spend roughly 70 percent of that cash on share buybacks and dividend hikes, while 30 percent of it will be invested into business improvements, such as mergers and acquisitions, debt paydowns, increased spending and more research.

“With Apple and [CEO Tim] Cook set to repatriate roughly $200 billion of cash based on our estimates, we believe accelerated buybacks, another dividend hike, and potentially larger [merger and acquisition] will be the trifecta of benefits shareholders could expect to see in 2018,” Ives says.

Image result for apple netflix

Apple has historically preferred to develop its own internal businesses rather than go after huge buyout targets, but Ives says the repatriation holiday may create a one-time opportunity for Apple to make a huge deal to acquire a big company like Netflix (NFLX). Ives says there is a perfect window of opportunity for Apple to make a blockbuster move to combat Netflix, Walt Disney Co (DIS), Amazon.com (AMZN) and Facebook (FB), all of which are spending aggressively on streaming video content.

“For a company that historically is not a huge fan of larger M&A and focused on organic initiatives to broaden its golden consumer ecosystem, a larger M&A deal around buying Netflix, a movie studio, and/or another avenue of adding significant content would be a cultural shift although potentially necessarily if Apple wants to make a big bet on the streaming front,” Ives says.

GBH has a “highly attractive” rating and $235 price target for Netflix and a “highly attractive” rating and $205 price target for Apple.

CVS Health Buying Aetna, Deal Valued At $78 Billion

0

CVS Health will acquire Aetna for roughly $69 billion in cash and stock in a first-of-its kind deal aimed at fending off challenges in retail and health care, the companies announced on Sunday.

The landmark agreement is one of the year’s largest so far. It comes as insurers are under pressure to lower medical costs, and retailers are under attack from new competitors, including an increasingly powerful Amazon. It creates the first health care triple threat, combining CVS’s pharmacy and pharmacy benefit manager (PBM) platform with Aetna’s insurance business.

According to the agreed terms, Aetna stockholders will receive $207 per share, $145 in cash and $62 in stock. Including debt, the deal is valued at $78 billion.

Upon the closing of the transaction, three of Aetna’s directors, including Chairman and CEO Mark Bertolini, will join the CVS board of directors. Aetna will operate as a stand-alone business unit within the larger company, led by members of the insurer’s current management team.

The transaction is expected to close in the second half of 2018, subject to regulatory and shareholder approval.

Wall Street, New York, NY, United States of America

“This combination brings together the expertise of two great companies to remake the consumer health care experience,” CVS President and CEO Larry Merlo said in a statement.

“With the analytics of Aetna and CVS Health’s human touch, we will create a health care platform built around individuals.”

Breaking new ground

The takeover comes as Amazon threatens to enter the drug industry. The retail juggernaut has held preliminary talks with makers of generic drugs about its potential entry into the pharmacy space, according to people familiar with the discussions.

With Amazon as a pharmacy competitor, CVS risks losing the key draw to its stores. Shoppers can already find CVS’s cosmetic and household staples in other retailers and online, often for cheaper.

CVS, which has a network of nearly 10,000 pharmacies and over 1,000 walk-in clinics, plans to use its vast retail footprint as a center for pharmacy, nutrition, clinical, vision and even beauty services. They will still sell traditional household goods.

The two will thus create a new touch point outside the costly hospital emergency room visits that insurance companies must pay for. They will add new reason to visit CVS stores.

By tying up with Aetna, CVS cements the move into health care it has been making since its acquisition of the Caremark PBM business in 2007. (A PBM typically is a third party that negotiates prescription drug benefits for a commercial health plan.)

The acquisition gives CVS more scale to bargain for better prices for the prescription drugs it sells through its PBM business. It also fortifies Aetna’s insurance business by creating the ability to offer its customers cheaper co-payments, presumably only in CVS stores.

It would also provide a tighter hold on patients who require more expensive, specialty drugs — the more profitable part of the business.

“These high complex-care cost members, the very, very sick, or the ones that are using expensive drugs, tend to be the highest profit for the industry,” said Pramod John, CEO of Vivio Health, a specialty pharmacy management firm.

For Aetna, the deal marks a change in strategy after its attempted tie-up with Humana was blocked by a federal court on antitrust grounds. The two, like others in the insurance industry, had sought out scale to better negotiate costs with hospitals and PBMs.

A CVS deal would be a so-called vertical integration — an acquisition along a company’s supply chain — rather than a horizontal acquisition of a direct competitor. Such deals are thought to be less threatening to antitrust authorities.

Still, AT&T, which is making the largest recent attempt at vertical integration with its proposed $85 billion acquisition of Time Warner, has been sued by the Department of Justice to stop the deal.

Barclays and Goldman Sachs served as financial advisors to CVS and Centerview Partners provided financial advice to the CVS board. CVS was advised on legal matters by Shearman & Sterling, Dechert, and McDermott Will & Emery.

Lazard and Allen & Company served as financial advisors to Aetna. Evercore served as financial advisor to Aetna’s board. Davis Polk & Wardwell acted as Aetna’s legal advisor.

Venezuelan Crude Exports To U.S. Fall To 15-year Lows

0

Venezuelan crude exports to the U.S. fell last month to their lowest levels since January 2003, according to new Reuters data.

Sanctions and low production caused the decline in November. The last time levels were this low, an industry strike had shut down a large portion of the Latin American nation’s oil sector.

State-run PDVSA sent a total of 475,165 barrels of oil the U.S. per day in November – a 36 percent drop from last year and a 12 percent drop from the previous month.

The last four years have seen the country lose one million bpd of production, mostly due to inadequate funds to maintain oil facilities, according to the OPEC. Three years of low oil prices have made it difficult for state revenues to meet national budget demands.

The output and revenue decline is causing Caracas to take oil from its joint ventures in the Orinoco Belt to keep the lights on. Hamaca crude from a joint venture with Chevron is increasingly being used for domestic refining instead of being exported to the U.S.

At the end of August, the U.S. stepped up its sanctions on Venezuela, prohibiting dealings in new debt or equity issued by PDVSA or the government. President Nicolas Maduro claims that the string of U.S. sanctions imposed this year on Venezuela amount to “financial persecution”.

Image result for pdvsa

In a surprise move at the end of last month, Maduro named a National Guard major general as the new head of PDVSA and the country’s oil ministry— Manuel Quevedo— who vowed to end corruption at PDVSA, but didn’t mention how he would approach the company’s huge foreign debt.

Analysts and bond investors will be closely following Quevedo’s statements and moves to try to figure out if the new chief will continue Maduro’s policy to try to service debt at all costs—even if payments are late—despite cash reserves quickly running out.

LNG Becomes A Buyer’s Market On Continuously Growing Supply

0

The world’s liquefied natural gas (LNG) market has dramatically changed over the past few years. Continuously growing supply has led to a glut, and the U.S. starting LNG exports has led to more flexible contract terms. LNG trade is increasingly shifting to a buyers’ market, where importers are shaping the future of the LNG trade deals with exporters.

Charif Souki, co-founder of the U.S. firm that upended LNG trade contracts, Cheniere Energy, has started a new company after being ousted from Cheniere two years ago. Now Souki’s new venture, Tellurian Inc, is talking with potential buyers who want to be not only importers but equity investors as well.

“Nobody is keen to sign contracts,” Souki told Bloomberg, “Even the people who kind of think they should are afraid to do it.”

“We’ve been approached by at least a dozen and a half people, companies, that say: ‘We’d like to participate with you. You know how to build facilities cheaply and we’ll trust you to go and find the resource,’” Souki said, recounting what buyers are telling him about potential deals.Tellurian plans to build the Driftwood LNG export facility near Lake Charles, Louisiana—with plans to export 26 million tons of LNG per year. The company expects to begin construction of Driftwood LNG in 2018, deliver first LNG in 2022, and ramp up the facility to full operations in 2025.

At the end of last year, France’s oil and gas supermajor Total SA signed a deal to buy a 23-percent stake in Tellurian for $207 million to develop an integrated gas project, from the acquisition of competitive gas production in the U.S. to the delivery of LNG to international markets from the Driftwood LNG terminal.

Last month, Tellurian signed a deal to buy natural gas producing assets and undeveloped acreage in northern Louisiana for $85.1 million, as part of its strategy to add production assets to grow its business.

“We expect our full cycle cost of production and transport to markets will be approximately $2.25 per MMBtu, which represents a significant savings to natural gas we will purchase at Henry Hub and other regional liquidity points,” Tellurian president and CEO Meg Gentle said.

Now potential LNG buyers want partnerships, not just supply deals, according to Souki, and to executives at other U.S.-based LNG developers who spoke to Bloomberg.

“Today, it’s the buyers’ market,” Leonid Mikhelson, CEO at Russia’s gas firm Novatek, recently told reporters, in a sign that LNG exporters around the world see that importers are dictating the market terms.

Last week, India’s Minister of Petroleum and Natural Gas, Dharmendra Pradhan, tweeted “As we increase the % of gas in our energy basket as cleaner fuel we need better terms & prices for our LNG import contracts.”

According to the International Energy Agency’s (IEA) Global Gas Security Review 2017, “Looking forward, the pool of legacy export contracts with fixed destination and long duration can be expected to shrink as these expire, and would be replaced by more flexible contracts.”

Last year, the share of flexible destination contracts continued to increase and made up 41.9 percent of newly signed volumes in 2016, the IEA’s review said. In addition, the average contract length has declined. For contracts signed before 2014, the average duration was 16 years, for deals in 2015 it was 10 years, and for contracts signed in 2016, the average duration was just 9 years.

“In fact, a greater proportion of new contracts have flexible terms (i.e. no destination clauses), encouraged by both the innovative business models of the US suppliers and policies in the consuming countries and territories. Expiring ‘legacy’ long-term contracts would also provide an opportunity to renegotiate terms towards more flexibility,” the IEA said.

At the beginning of this year, James Walker, a specialist with Energy Insights at McKinsey, wrote:

“‘Short-termism’ is growing in the LNG market, which is increasingly characterized by greater spot availability, shorter term supply contracts and buyers diversifying their portfolios to capitalize on the current market oversupply.”

McKinsey expects the LNG market to continue to be oversupplied through 2024, but China having “great potential to absorb a large share of the surplus volumes from 2018 onwards.”

In the current state of the LNG market, it’s now a buyers’ world.

Why These Biotech Stocks Could Be Taken Over In 2022

0

Clovis Oncology (CLVS), Sage Therapeutics (SAGE) and Puma Biotechnology (PBYI) could stoke acquisitive appetites in 2018 as large-cap biotechs struggle with slowing growth and major patent cliffs, analysts said Tuesday.

Deal-making has slowed since hitting a record high in 2015, RBC analysts said in a note to clients. The number of deals valued above $1 billion hit 17 two years ago. This year, there have been six of those mergers, including Gilead Sciences’ (GILD) $11.9 billion takeover of Kite Pharma.

Investors had expected Gilead’s major buy to stoke more acquisitions. When that didn’t come to fruition, biotech stocks suffered. But “pent-up demand” could prompt mergers and acquisitions to play out next year, analysts say.

Related image

“Many large-cap companies generate a disproportionate share of overall revenues from a handful of blockbuster drugs — many of which are facing impending patent cliffs in the coming years,” RBC’s note said. “The need to make up for lost sources of revenue and stimulate growth may encourage future M&A.”

Gilead bought Kite after suffering major declines in its hepatitis C drug unit. But its HIV drug, tenofovir alafenamide, is likely to lose patent protection in 2025. Celgene’s (CELG) cancer drug Revlimid is facing patent cliffs in 2024-26. Amgen’s (AMGN) anti-inflammatory Enbrel is likely to lose protection in 2019.

These three also had the most cash on hand as of their recent updates. Amgen reported $41.35 billion, Celgene had $11.76 billion and Gilead noted $29.07 billion. The remainder of large-caps in the biotech realm had under $4 billion each.

Related image

Overall, cash positions are nearing a five-year high, analysts say. Tax reform could help. Under the most recent proposal, companies can repatriate earnings at as a 15.5% tax rate. Amgen, Bristol-Myers Squibb (BMY) and Dow’s Johnson & Johnson (JNJ) have an excess of 90% of their cash currently overseas.

“However, we think it’s unlikely that the majority of overseas cash would be repatriated immediately upon institution of tax reform,” RBC analysts said. Celgene, for instance, has suggested a chunk of its foreign earnings are expected to be reinvested permanently outside the U.S.

Analysts also note the average projected revenue for the next seven years for mid-cap biotechs is likely to do little to offset the losses from patent cliffs. Performance of acquirers over the past two years has been poor. Industry checks also indicate large deals are on the outs — Gilead/Kite being the exception.

Related image

Still, expectations are high for mergers and acquisitions, analysts say. In a recent survey, investors cited M&A as the biggest tailwind for the group. Drug pricing is expected to be the biggest headwind in 2018. RBC analysts are slightly bullish on M&A and slightly bearish on drug pricing.

“With expectations high for M&A as a major tailwind for the sector, if it does not materialize in the first half of 2018, we could see broad downside,” RBC said.

Credit Suisse analyst Vamil Divan, too, notes M&A will be important for the Big Pharma group and that it will likely come as a result of changes in tax rates for repatriation. His top pick for 2018 is J&J, though he also expects Dow’s Merck (MRK) and Allergan (AGN) to rebound.

“Additional funds for dividend growth and share repurchases should also boost the overall outlook for the sector from an investor perspective,” he said. “We see the regulatory environment remaining generally favorable and providing more rapid paths to market for products that bring real innovation.”

CME Launching Bitcoin Futures After Green Light From Regulator

0

CME announced Friday its new bitcoin futures contract will be available for trading on Dec.18.

The CME announcement came as the Commodity Futures Trading Commission said it will allow the world’s largest futures exchange and its competitor, the Cboe Futures Exchange, to launch bitcoin contracts. Cantor Exchange also self-certified a new contract for bitcoin binary options, the commission said.

Bitcoin traded more than 6 percent higher at $10,539 on Friday, recovering partly from a 20 percent drop to $9,021.85 from a record high of $11,377.33 hit Wednesday, according to CoinDesk.

“I think it is going to enable finally the approval of bitcoin ETFs, and other digital currency ETFs, which is game changing,” Barry Silbert, founder and CEO of Digital Currency Group, said on CNBC’s “Squawk Box.”

Wall Street, New York, NY, United States of America

CME’s announcement comes as other major exchanges rush to launch their own bitcoin derivatives products.

Shares of CME spiked 1.7 percent to an all-time high Friday morning. Cboe’s stock traded little changed after setting a record close Thursday.

The CFTC does not approve derivatives contracts or endorse their underlying assets.

“Commission staff held rigorous discussions with CME over the course of six weeks, CFE over the course of four months, and had numerous calls with Cantor,” a CFTC release said.

“Bitcoin, a virtual currency, is a commodity unlike any the Commission has dealt with in the past,” CFTC Chairman J. Christopher Giancarlo said in a statement. “As a result, we have had extensive discussions with the exchanges regarding the proposed contracts, and CME, CFE and Cantor have agreed to significant enhancements to protect customers and maintain orderly markets.”

In a separate release Friday, Cboe said it has filed a product certification with the Commodity Futures Trading Commission to offer bitcoin futures trading. The certification is subject to regulatory review and a launch date “will be announced shortly,” according to a release.

A Cboe spokesperson initially told CNBC the bitcoin futures launch is expected “probably before the end of the year,” but later clarified, saying the exchange couldn’t be that specific. “We are operationally ready and we will be announcing a launch date shortly,” the spokesperson said in new statement.

Nasdaq plans to launch bitcoin futures as early as the second quarter of 2018, exchange officials told CNBC on Thursday. Nasdaq would base its price off of 50 bitcoin sources from around the world, while Cboe is currently using one and the CME is using four, a Nasdaq spokesperson said.

Mining Profits Are Super-charged And BlackRock Wants To Get Paid

0

(Bloomberg) — The world’s mining sector is firing on all cylinders again, and one of it’s biggest investors can’t wait to get paid.

After five years of under-performance, a combination of synchronous global growth and under-investment in new supply has driven up commodity prices, increasing cash flow and profit margins for the world’s biggest mining companies, according to BlackRock Inc.’s Evy Hambro.

BlockRock (BLK) 1-Year Chart

“When those things converge you get a pretty explosive price response, and that’s what we’ve seen,” Hambro, who manages BlackRock’s $6.4 billion World Mining Fund, said in a Bloomberg TV interview on Thursday. “Margins and cash flows for the sector are going to continue to be very robust, and we are really looking forward to getting rewarded for our patience with the companies handing back cash to us.”

Lion ferrochrome smelter, South Africa

Mining companies were forced to shed assets to cut debt and reassure investors during a 2015 collapse in commodity prices that threatened the survival of some of the biggest names in the industry. The slump wiped out more than $1.4 trillion of shareholder value and revealed years of profligate spending by mining executives on ambitious projects to feed inflated forecasts for Chinese demand.

“A lot of investors were really badly burned, ourselves included,” Hambro said. His fund posted negative returns for five years from 2011, losing 41 percent of its value in 2015 as mining stocks plummeted. “That takes time for people to forget and to trust the management teams not to repeat the same mistakes,” he said.

Growth has returned for miners and BlackRock in the last two years. The FTSE 350 Mining Index is up more than 200 percent in the last two years, while Hambro’s fund made returns of 31 percent last year, compared with an average 15 percent among its peers, according to data compiled by Bloomberg.

Truck dumps load of ore at El Abra Copper Mine, Calama, (northern) Chile

With many miners having paid down debt, the focus should be on returning cash to shareholders, according to Hambro. Companies need to be disciplined about how they allocate capital and only invest in project development or acquisitions when they can show investors a return on investment at “reasonable” commodity prices.

If they do that, more investors will return, he said. “The discount that the sector is trading at relative to the historic multiples is a reflection of the underweight that most investors have to this sector.”

With commodities including copper, zinc, nickel, iron ore and thermal coal all rallying, those investors might not want to wait too long.

“The margins at these prices are enormous and they are not reflected in today’s valuations,” he said. “That is the arbitrage opportunity in the market.”

Get in touch

567FollowersFollow
388FollowersFollow
1,251FollowersFollow

Recent Posts

Most Popular

SKYX Platforms (NASDAQ: SKYX) posts massive 2023 sales increase as demand for their game-changing...

Technology companies are the profit-leading stocks in the market today! While trendy stocks may come and go with temporary appeal, there's no substitute for soaring...

Lithium price soars to all-time high as supply struggles to feed EV growth

The surge in prices of lithium, the key battery material used to power electric cars, is seemingly unstoppable. Lithium carbonate hit a fresh record of...

New GM App Lets You Order Starbucks While You Drive

Thanks to the invention of cupholders, we can all safely drink coffee while we drive. And now, thanks to a new app from GM, we...

TransCanada Recovers 44,400 Gallons Of Oil From Keystone Pipeline Spill Site

TransCanada Corp said on Friday it has recovered 44,400 gallons, or 1,057 barrels, of oil from the Keystone pipeline spill site at Amherst, South...

Biotech Stock Rockets To Record On Gene Therapy Trial In Children

Audentes Therapeutics (BOLD) rocketed to an all-time high Thursday (1/11/18) after its gene therapy showed promising results in a Phase 1 and Phase 2...